- Category rank
- #9 of 13 in Imaging
- Confidence
- Medium (60%)
- Last reviewed
- October 15, 2026
Represent Diagnocat and think this score is inaccurate? Request a score review · Score changelog
| Criterion | Weight | Score |
|---|---|---|
Regulatory evidence US FDA clearance is recent and narrow: K252934 (Jan 2026) covers periapical radiolucency on CBCT. | 30% | 6.5 |
Detection scope Vendor reports 40+ conditions on 2D and 60+ on 3D scans, plus auto charting. | 20% | 9.0 |
Imaging & PMS integrations Connects to PMS, x-ray and intraoral scanners per the vendor; US PMS list not published. | 20% | 7.5 |
Chairside patient communication Patient-friendly, print-ready visual reports. | 15% | 8.5 |
Scale & support Large international base, but the US launch only came in late 2025; vendor quotes a 2-week onboarding. | 15% | 6.5 |
Weighted result 7.5. Last reviewed Oct 17, 2026. How we score · Request a score review